ProQR Therapeutics (PRQR) Q4 2024 Earnings
PRQR·Reported March 13, 2025·Before market open
ProQR Therapeutics reported Q4 2024 revenue of $4.5M, missed analyst consensus of $5.4M by $985.6K. Diluted EPS came in at $-0.10.
Revenue
$4.5Mmissed by $985.6K
Consensus: $5.4MDiluted EPS
$-0.10met estimate
Consensus: $-0.10
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about ProQR Therapeutics's Q4 2024 earnings report.
ProQR Therapeutics (PRQR) reported Q4 2024 earnings on March 13, 2025 before market open.
ProQR Therapeutics reported revenue of $4.5M and diluted EPS of $-0.10 for Q4 2024.
Revenue missed the consensus estimate of $5.4M by $985.6K. EPS beat the consensus estimate of $-0.10 by $0.00.